📰 Eva Kalias News
Page 7 - Eva Kalias News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Eva Kalias. Real-time updates on events, politics, business and more.
February 28, 2022
Pratteln, Switzerland, February 28, 2022 - Santhera Pharmaceuticals (SIX: SANN) announces the signing of an agreement with SEAL Therapeutics for a gene therapy approach targeting congenital muscular dystrophy.
February 18, 2022
Investegate announcements from Santhera Pharmaceuticals Holdi, Santhera Completes Repayment of 2017/22 Convertible Bonds
February 18, 2022
Pratteln, Switzerland, February 18, 2022 - Santhera Pharmaceuticals (SIX: SANN) announces full redemption of its senior unsecured convertible bonds (the 2017/22 Bonds, ISIN CH0353955195), effective
January 4, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
December 15, 2021
Pratteln, Switzerland, December 15, 2021 - Santhera Pharmaceuticals (SIX: SANN) announces that its shareholders have approved all proposals by the Board of Directors at the Extraordinary General Meeting
December 15, 2021
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
December 15, 2021
Investegate announcements from Santhera Pharmaceuticals Holdi, Santhera’s Shareholders Approve all Board Proposals at Today’s Extraordinary General Meeting
December 6, 2021
Pratteln, Switzerland, December 6, 2021 - Santhera Pharmaceuticals (SIX: SANN) is pleased to invite investors, shareholders, media representatives and interested parties to join a conference call
November 23, 2021
Ad hoc announcement pursuant to Art. 53 LR Vamorolone given throughout the study showed sustained efficacy across multiple endpoints over 48 weeks and the...
November 23, 2021
Ad hoc announcement pursuant to Art. 53 LR Vamorolone given throughout the study showed sustained efficacy across multiple endpoints over 48 weeks and the good safety and tolerability profile